These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7307999)

  • 21. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate.
    Williams DO; Bommer WJ; Miller RR; Amsterdam EA; Mason DT
    Am J Cardiol; 1977 Jan; 39(1):84-90. PubMed ID: 318795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative evaluation of the effectiveness of various peripheral vasodilators in the treatment of cardiac insufficiency].
    Mukharliamov NM; Mareev VIu; Novikov SV; Evdokimova NKh; Ageev FT
    Ter Arkh; 1985; 57(5):89-94. PubMed ID: 3927501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term action of nitrites in coronary heart disease (author's transl)].
    Wolf R; Beck OA; Krämer KD; Hochrein H
    Dtsch Med Wochenschr; 1975 Apr; 100(14):735-42. PubMed ID: 805039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Vasodilator therapy of congestive heart failure].
    Schröder R
    Dtsch Med Wochenschr; 1977 Sep; 102(39):1388-94. PubMed ID: 410617
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of advanced heart failure with hydralazine and isosorbide dinitrate (author's transl)].
    Lanas F; Salvatici R; Opazo JA; Saavedra J; Iturriaga J
    Rev Med Chil; 1979 Oct; 107(10):926-30. PubMed ID: 550229
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of chronic congestive failure with vasodilators (acute trial with prazosin and erythrityl tetranitrate)].
    Tomov I; Kaloianova A; Terzieva L; Nikolov G; Elenkova A
    Vutr Boles; 1982; 21(6):45-50. PubMed ID: 6761964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vasodilators in the treatment of congestive heart failure.
    Ciafone RA
    Conn Med; 1983 Oct; 47(10):614-8. PubMed ID: 6414758
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of severe chronic cardiac insufficiency with dihydralazine. Short-and median-term results].
    Morand P; Lavigne G; Masson D; Latour F; Alison D
    Arch Mal Coeur Vaiss; 1979 Mar; 72(3):268-75. PubMed ID: 114137
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of nitroglycerin in acute myocardial infarction. III. Isosorbide dinitrate in patients with or without left-heart failure (author's transl)].
    Bussmann WD; Löhner J; Kaltenbach M
    Dtsch Med Wochenschr; 1975 Oct; 100(40):2003-9. PubMed ID: 1157716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dihydralazin versus prazosin. The hemodynamic effect of the modul substances (author's transl)].
    Komarek J; Cartheuser CF
    Z Kardiol; 1977 Dec; 66(12):706-11. PubMed ID: 602353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of a combination of sublingually administered vasodilating drugs for rapid action on pulmonary hypertension in patients with cardiac asthma and with pulmonary oedema.
    Daskalov TR
    Cor Vasa; 1987; 29(3):222-31. PubMed ID: 3113825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary evidence for the mechanism underlying the development of tolerance to prazosin in congestive heart failure: the alpha-agonistic properties of dobutamine unmasked by prazosin treatment.
    Kersting F; Kupp M; Giesen G
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):537-43. PubMed ID: 7681897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of effectiveness of dihydralazine in the long-term treatment of chronic heart failure.
    Reifart N; Kaltenbach M; Bussmann WD
    Eur Heart J; 1984 Jul; 5(7):568-80. PubMed ID: 6479183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure.
    Leier CV; Huss P; Magorien RD; Unverferth DV
    Circulation; 1983 Apr; 67(4):817-22. PubMed ID: 6337742
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasodilators in heart failure secondary to coronary artery disease.
    Parmley WW; Rouleau JL; Chatterjee K
    Am Heart J; 1982 Apr; 103(4 Pt 2):625-32. PubMed ID: 7064804
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasodilator therapy for chronic left ventricular failure.
    Kovick RB; Tillisch JH; Berens SC; Bramowitz AD; Shine KI
    Circulation; 1976 Feb; 53(2):322-8. PubMed ID: 812614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Peripheral vasodilators in the treatment of heart failure].
    Serbin VI; Gasanova AS
    Pediatriia; 1982 Jan; (1):67-70. PubMed ID: 7038611
    [No Abstract]   [Full Text] [Related]  

  • 38. [Vasodilator therapy by isosorbide dinitrate for the patients with congestive heart failure (author's transl)].
    Ogasawara B; Kai I; Kondo T; Watanabe E; Okubo M; Sassa H; Niwa T; Matsui E
    Nihon Naika Gakkai Zasshi; 1978 Jan; 67(1):24-34. PubMed ID: 632635
    [No Abstract]   [Full Text] [Related]  

  • 39. Radionuclear measurement of peripheral hemodynamics in selection of vasodilators for treatment of heart failure.
    Todo Y; Ohyanagi M; Fujisue R; Iwasaki T
    J Nucl Med; 1988 Apr; 29(4):451-9. PubMed ID: 3351600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of vasodilators on renal function in severe heart failure.
    Mantle JA; Russell RO; Tauxe WN; Dustan HP; Rogers WJ; Rackley CE
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2399-403. PubMed ID: 7422530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.